Clinical Trial Update: Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update assessing a near-infrared fluorescent agent for sentinel lymph node mapping in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Near-infrared fluorescent sentinel lymph node imaging agent

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED